Lung Disease Management by Iloprost-Loaded Nanoparticles to Address Hyperinflammation Associated with Cystic Fibrosis-Reference-Cited by-同舟云学术

Lung Disease Management by Iloprost-Loaded Nanoparticles to Address Hyperinflammation Associated with Cystic Fibrosis

Published:2024-06-11 Issue:12 Volume:7 Page:14077-14089
ISSN:2574-0970
Container-title:ACS Applied Nano Materials
language:en
Short-container-title:ACS Appl. Nano Mater.

Author:

Craparo Emanuela F.¹²^ORCID,Cabibbo Marta¹^ORCID,Scialabba Cinzia¹^ORCID,Laselva Onofrio³^ORCID,Daniello Valeria³^ORCID,Di Gioia Sante³^ORCID,Conese Massimo³^ORCID,Cavallaro Gennara¹²^ORCID

Affiliation:

1. Laboratory of Biocompatible Polymers, Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, Palermo 90123, Italy

2. National Interuniversity Consortium for Materials Science and Technology (INSTM), UdR of Palermo, Via Giusti 9, Florence 50125, Italy

3. Department of Clinical and Experimental Medicine, University of Foggia, Biomedical Research Center “E. Altomare”, Via Napoli 121, Foggia 71122, Italy

Funder

European Commission

Ministero dell?Istruzione, dell?Universit? e della Ricerca

Regione Siciliana

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsanm.4c01379

Reference48 articles.

1. Receptor-mediated activation of CFTR via prostaglandin signaling pathways in the airway

2. Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies

3. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy

4. Inflammation in cystic fibrosis: An update

5. Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies